MECP2 and Rett syndrome: The majority of RTT individuals carry loss-of-function mutations in MECP2, the gene encoding methyl CpG-binding protein 2 (MeCP2), a global transcriptional regulator that binds to methylated CpG sites in promoter regions of DNA (Amir et al., 1999; Chahrour et al., 2008).